KINASE INHIBITORS

Lisa Nodzon, PhD, APRN, AOCNP^®, of Moffitt Cancer Center, and Anecita Fadol, PhD, APRN, FAANP, FAAN, of MD Anderson Cancer Center, break down a complex case of ibrutinib-associated atrial fibrillation, an adverse event that requires multidisciplinary collaboration.